Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Jun 30, 2025
Date Accepted: Dec 16, 2025
CBT-based Massed Brief Psychoeducational Group via Videoconference for Social Anxiety: A Randomized Controlled Trial
ABSTRACT
Background:
Group cognitive-behavioral therapy (CBT), delivered through weekly videoconference sessions, has been shown to effectively reduce social anxiety. However, no studies have evaluated CBT delivered via videoconference in a two-day massed brief psychoeducational group format.
Objective:
This randomized controlled trial aimed to evaluate the efficacy of a videoconferencing CBT-based massed brief psychoeducational group among Chinese university students with social anxiety.
Methods:
University students with social anxiety were recruited online and randomly assigned to an intervention group or a waitlist control group. Participants in the intervention group attended a two-day workshop via videoconference. Assessments were conducted at baseline (T1), posttest (T2), one-month follow-up (T3), and three-month follow-up (T4), using the Social Phobia Inventory (SPIN), Brief Fear of Negative Evaluation Scale (BFNES), Depression Anxiety Stress Scales—Short Form (DASS-21), Social Anxiety Knowledge Test (SAKT), Social Anxiety Stigma Inventory (SASI), and Attitudes Toward Seeking Professional Psychological Help Scale—Short Form (ATSPPH-SF).
Results:
The intervention group showed significant reductions in SPIN scores (β = -4.00, 95% bootstrap CI [-6.55, -1.22]; dT2-4 = -0.97 to -0.81) and BFNES scores (β = -1.37, 95% bootstrap CI [-2.64, -0.08]; dT3 = -0.56), as well as significant increases in SAKT scores (β = 0.62, 95% bootstrap CI [0.05, 1.17]; dT2-4 = 0.86 to 1.53). No significant changes were observed in DASS-21, SASI, or ATSPPH-SF scores.
Conclusions:
Findings indicate that videoconferencing CBT-based massed brief psychoeducational group was effective in reducing social anxiety among university students. Future research with larger and more diverse samples is recommended to validate the efficacy and assess the scalability of this intervention format. Clinical Trial: Chinese Clinical Trial Registry ID: ChiCTR2400093444; https://www.chictr.org.cn
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.